Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Inappropriate schedule of product administration, Lymphadenopathy, Nausea
Clinical narrative: Body aches; Very Achy; Swollen Lymph nodes; Nausea; Pain at injection site; Prev dose administration date: 25Apr2021/ Administration date: 02Oct2021; Horrible headache; Extreme fatigue; Had sore left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Oct2021 14:45 (Lot number: FD0809) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure; "Hypothyroid" (unspecified if ongoing), notes: Hypothyroid; "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medication(s) included: POTASSIUM. Vaccination history included: Bnt162b2 (Prev dose Brand: Pfizer BioNTech, Prev dose Administration time: 11:30 AM, Prev dose Vaccine location: Left arm, Route of administration: Intramuscular, Lot Number : misplaced/discarded), administration date: 25Apr2021, when the patient was 59 years old, for COVID-19 Immunization. The patient received medication within 2 weeks of vaccination were hypothyroid med, thyroid med.  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 02Oct2021 14:30, outcome "unknown", described as "Prev dose administration date: 25Apr2021/ Administration date: 02Oct2021"; FATIGUE (non-serious) with onset 01Oct2021 16:00, outcome "recovered" (04Oct2021), described as "Extreme fatigue"; HEADACHE (non-serious) with onset 01Oct2021 17:00, outcome "recovered" (05Oct2021), described as "Horrible headache"; VACCINATION SITE PAIN (non-serious) with onset 02Oct2021 16:00, outcome "not recovered", described as "Pain at injection site"; PAIN (non-serious) with onset 03Oct2021 16:00, outcome "recovered" (05Oct2021), described as "Very Achy"; NAUSEA (non-serious) with onset 02Oct2021 16:00, outcome "not recovered", described as "Nausea"; LYMPHADENOPATHY (non-serious) with onset 03Oct2021 09:00, outcome "recovered" (11Oct2021), described as "Swollen Lymph nodes"; PAIN IN EXTREMITY (non-serious) with onset 01Oct2021, outcome "recovered" (04Oct2021), described as "Had sore left arm"; PAIN (non-serious), outcome "unknown", described as "Body aches". Therapeutic measures were not taken as a result of fatigue, headache, vaccination site pain, pain, nausea, lymphadenopathy, pain.  Additional information: Seriousness criteria was not Results in death, Life threatening Caused/prolonged hospitalization and Congenital anomaly/birth defect. Prior to vaccination, patient did not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.After 2nd dose 01Oct2021 also had sore left arm for 3 days was nauseated 1st day fatigue started after a few hours lasted 3 days, very achy like non over started 03Oct2021 lasted 2 days.  No follow-up attempts are possible. No further information is expected.